(19)
(11) EP 1 218 520 A1

(12)

(43) Date of publication:
03.07.2002 Bulletin 2002/27

(21) Application number: 00965361.9

(22) Date of filing: 22.09.2000
(51) International Patent Classification (IPC)7C12N 15/61, C12N 9/90, C12Q 1/533, C07K 16/40
(86) International application number:
PCT/US0026/146
(87) International publication number:
WO 0121/815 (29.03.2001 Gazette 2001/13)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 23.09.1999 US 404628

(71) Applicant: Rigel Pharmaceuticals, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • LUO, Ying
    Los Altos, CA 94022 (US)
  • CHAN, Eva
    San Francisco, CA 94132 (US)

(74) Representative: Kiddle, Simon John et al
Mewburn Ellis,York House,23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) CHECKPOINT GENE ASSOCIATED CELL CYCLE PROTEINS, COMPOSITIONS AND METHODS OF USE